Featured Research

from universities, journals, and other organizations

Tracking the birth of evolutionary arms race between HIV-like viruses and primate genomes

Date:
January 26, 2012
Source:
Fred Hutchinson Cancer Research Center
Summary:
Using a combination of evolutionary biology and virology, scientists have traced the birth of the ability of some HIV-related viruses to defeat a newly discovered cellular-defense system in primates.

Using a combination of evolutionary biology and virology, scientists at Fred Hutchinson Cancer Research Center have traced the birth of the ability of some HIV-related viruses to defeat a newly discovered cellular-defense system in primates.

The research, led by Michael Emerman, Ph.D., a member of the Hutchinson Center's Human Biology and Basic Sciences Division, and Harmit Malik, Ph.D., a member of the Center's Basic Sciences Division, was published online Jan. 26 ahead of the Feb. 16 print issue of Cell Host & Microbe.

The work, which also involved researchers in the Hutchinson Center's Computational Biology Program, hinges on the recently discovered cellular-defense protein called SAMHD1, which protects some key cells of the immune system from infection by HIV-1. The protein likely accomplishes this by reducing the available nucleotides, or DNA building blocks, the virus needs for replicating. In response, some viruses related to HIV-1, such as HIV-2 and some simian immunodeficiency viruses that infect other primates, produce a protein called Vpx that binds to SAMHD1 and targets it for destruction.

HIV-1, however, does not encode Vpx, but it does encode a related protein called Vpr. Emerman and colleagues tried to address the question of whether HIV-1 lost the ability to degrade SAMHD1 or whether this ability was gained only in the minority of lentiviruses that encode a Vpx protein.

To distinguish between these possibilities, the researchers tested both Vpx as well as the related Vpr proteins from a panel representing all currently known primate lentiviruses for their ability to bind and degrade SAMHD1. When the phylogenetic history, or evolutionary relatedness, between these two viral proteins was mapped on top of their functions, the researchers found that SAMHD1-degrading ability was acquired first by the Vpr protein before the Vpx protein was even "born."

This new function occurred only once, in a single evolutionary lineage representing three of eight currently known primate lentivirus types. "This means that the ability of lentiviruses to degrade primate SAMHD1 is a newly acquired trait," Emerman said. "However, HIV-1 does not have the capacity to degrade SAMHD1 because its Vpr gene derived from a lineage of viruses in primates that never evolved to gain this function."

The researchers also found that Vpr/Vpx proteins have highly species-specific abilities to degrade primate SAMHD1. Thus, while a lentivirus can degrade SAMHD1 within a single primate species, it cannot bind and degrade the SAMHD1 protein from a more distantly related species. The specificity of the virus for its particular host and the fact that SAMHD1 degradation was an evolutionary novelty among lentiviruses suggests that SAMHD1 from some primates is locked in an "evolutionary arms race" with Vpx/Vpr proteins.

Such genetic tugs of war exemplify what is known among evolutionary biologists as the Red Queen Principle, a phrase borrowed from the Red Queen in Lewis Carroll's "Through the Looking Glass" that refers to the paradox of running as fast as you can just to stay in place. "Red Queen conflicts" typically put pressure on both sparring partners to continually evolve new ways to outsmart and overcome each other just to stay in the game. In this case, the host proteins evolve to evade degradation by the newly evolved viral proteins.

To assess molecular signatures of these evolutionary arms races, first author Efrem Lim, a graduate student in Emerman's lab, compared the evolutionary rates of SAMHD1 across primate evolution. He found that prior to 23 million years ago, there was very little evidence for rapid evolution of SAMHD1. In contrast, SAMHD1 proteins in Old World monkeys that harbor Vpr/Vpx-containing lentiviruses have evolved rapidly for millions of years.

"We have not only recreated the birth of SAMHD1-degrading activity in these viruses but also have captured the immediate evolutionary consequence on the host genes they antagonize," said Malik, an evolutionary geneticist. "While such arms races between viruses and host genomes have been documented previously, this is the first instance where the beginning of the Darwinian arms race has been captured in both viral and primate genomes." Emerman, a virologist, speculates the research may have direct implications for HIV-1 and AIDS. "It is possible that HIV-1 is so pathogenic because it needs to grow rapidly in order to compensate for the lack of the ability to deal with SAMHD1," he said.

The National Institutes of Health, National Science Foundation and the Howard Hughes Medical Institute supported the research.


Story Source:

The above story is based on materials provided by Fred Hutchinson Cancer Research Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Efrem S. Lim, Oliver I. Fregoso, Connor O. McCoy, Frederick A. Matsen, Harmit S. Malik, Michael Emerman. The Ability of Primate Lentiviruses to Degrade the Monocyte Restriction Factor SAMHD1 Preceded the Birth of the Viral Accessory Protein Vpx. Cell Host & Microbe, 26 January 2012 DOI: 10.1016/j.chom.2012.01.004

Cite This Page:

Fred Hutchinson Cancer Research Center. "Tracking the birth of evolutionary arms race between HIV-like viruses and primate genomes." ScienceDaily. ScienceDaily, 26 January 2012. <www.sciencedaily.com/releases/2012/01/120126123059.htm>.
Fred Hutchinson Cancer Research Center. (2012, January 26). Tracking the birth of evolutionary arms race between HIV-like viruses and primate genomes. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/01/120126123059.htm
Fred Hutchinson Cancer Research Center. "Tracking the birth of evolutionary arms race between HIV-like viruses and primate genomes." ScienceDaily. www.sciencedaily.com/releases/2012/01/120126123059.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins